Abstract

Objective: This study aimed to establish a genetic correlation between inflammatory cytokines (IC) and benign prostatic hyperplasia (BPH) to present an empirical reference for BPH treatment. Methods: Single nucleotide polymorphism (SNP) data were derived from two genome-wide association studies of IC and BPH. Forward Mendelian randomization (MR) analysis was carried out by the inverse variance weighting method with IC-related SNPs as the instrumental variable and BPH as the outcome, while the reverse MR analysis used BPH-related SNPs as the instrumental variable and IC as the outcome. Results: The results from forward MR analysis showed that there was no statistical differences between 51 ICs and BPH at the genetic level (P>0.05). Reverse MR analysis showed that BPH was significantly correlated with one type of IC at the genetic level (P<0.05), while the rest were no statistical differences (P>0.05). Conclusion: There was no bidirectional relationship between IC and BPH at the genetic level, suggesting that genetic exposure of IC may have no effect on BPH.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call